WOMEN’S HEALTH RESEARCH ROADMAP.

SEC. 3622. WOMEN’S HEALTH RESEARCH ROADMAP. Not later than 2 years after the date of enactment of this Act, the Office of Women’s Health of the Food and Drug Administration, established under section 1011 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 399b), shall—(1) review and, as appropriate, update the Women’s Health Research Roadmap issued in December 2015; and (2) brief the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives on the review and, as appropriate, any resulting update.